Recombinant human growth hormone treatment of children on hemodialysis
✍ Scribed by Etienne Bérard; Hélène Crosnier; Anne Six-Beneton; Thierry Chevallier; Pierre Cochat; Michel Broyer; on behalf of the French Society of Pediatric Nephrology
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 185 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0931-041X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We studied the effects of recombinant human growth hormone (GH) treatment in 6 prepubertal children with achondroplasia. The patients' age ranged from 2'!'12 to 85/12 years and the GH dose was of 0.1 IU/kg/ day subcutaneously. Auxological assessments and bone age determinations were performed 6 mont
Twenty patients with rheumatoid arthritis or Still's disease associated with growth failure were treated with human growth hoi'mone, 7.5 to 1 7 U / m 2 body surface per week. Five patients did not respond with better growth. In the remainder the mean growth rate increased from 1.9 cm/year (range: 0